Immunovant Inc

+0.18 (+1.36%)
4:09:54 PM EDT: $13.12 -0.28 (-2.09%)
Earnings Announcements

Immunovant Reports Financial Results For The Quarter Ended Sept 30

Published: 11/04/2022 11:18 GMT
Immunovant Inc (IMVT) - Immunovant Reports Financial Results and Recent Business Updates for the Quarter Ended September 30, 2022.
Quarterly Loss per Share $0.41.
Pro Forma Cash Balance of $476 Million Expected to Extend Cash Runway Into Second Half of Calendar Year 2025.
Q2 Earnings per Share View $-0.39 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.36

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.40

More details on our Analysts Page.